Table 3.
Overall N=113 | HBeAg-negative N=56 | HBeAg-positive N=57 | |
---|---|---|---|
Median ALT (IQR)(U/L)* | 25.5 (19.0–38.0) | 23 (17.5–33.0) | 28 (21.9–49.0) |
Median AST (IQR)(U/L)* | 34.0 (27.0–44.0) | 31.5 (24.0–40.0) | 36 (29.0–55.0) |
Detectable HBV DNA (>200 IU/ml (%))* | 91.2 | 83.9 | 98.2 |
Median HBV DNA (IQR)(log IU/ml)* | 5.1 (2.7–8.1) | 2.7 (2.3–4.4) | 8.0 (5.6–8.6) |
HBV genotype (number)† | |||
A | 68 | 33 | 35 |
C | 5 | 2 | 3 |
D | 15 | 4 | 11 |
E | 4 | 1 | 3 |
F | 3 | 0 | 3 |
AAL reactivity (number)‡ | |||
1–2 | 39 | 18 | 21 |
3–5 | 48 | 26 | 22 |
>5 | 16 | 8 | 8 |
P< 0.05 comparing HBeAg-negative to HBeAg-positive
HBV genotype not determined in 15 due to inability to amplify
Missing in 12 subjects